AHA Advice
Do you remember the big news when some common big-name arthritis medications that inhibited cox-2 enzymes (those responsible for the pain response) were taken off the market because of their link to heart attacks? The American Heart Association has formally issued a statement, recently published in Circulation, according to HealthDay, confirming that these drugs do increase the risk of heart attack and stroke, and stating that doctors need to prescribe the pain relievers still on the market (like Celebrex) to people with, or at risk for, heart disease only as a last resort.
Seems like a no-brainer to me. It’s good to have the official AHA position. I just wish it included recognition of the non-drug option for a cox-2 inhibitor!
Subscribe to Feed